Palladium Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $1.31M | Sell |
2,221
-1
| -0% | -$574 | 0.06% | 174 |
|
|
2021
Q4 | $1.48M | Hold |
2,222
| – | – | 0.06% | 168 |
|
|
2021
Q3 | $1.27M | Sell |
2,222
-2,163
| -49% | -$1.19M | 0.06% | 172 |
|
|
2021
Q2 | $2.21M | Buy |
4,385
+2,156
| +97% | +$1.02M | 0.1% | 127 |
|
|
2021
Q1 | $1.02M | Sell |
2,229
-90
| -4% | -$43K | 0.05% | 183 |
|
|
2020
Q4 | $1.08M | Sell |
2,319
-45
| -2% | -$21.1K | 0.06% | 158 |
|
|
2020
Q3 | $1.04M | Sell |
2,364
-11
| -0.5% | -$4.54K | 0.07% | 154 |
|
|
2020
Q2 | $861K | Sell |
2,375
-65
| -3% | -$21.8K | 0.06% | 159 |
|
|
2020
Q1 | $692K | Sell |
2,440
-50
| -2% | -$15.8K | 0.06% | 159 |
|
|
2019
Q4 | $809K | Sell |
2,490
-912
| -27% | -$277K | 0.05% | 168 |
|
|
2019
Q3 | $830K | Sell |
3,402
-208
| -6% | -$59.6K | 0.06% | 161 |
|
|
2019
Q2 | $1.06M | Sell |
3,610
-110
| -3% | -$30.3K | 0.07% | 154 |
|
|
2019
Q1 | $1.02M | Buy |
3,720
+318
| +9% | +$79.1K | 0.07% | 150 |
|
|
2018
Q4 | $761K | Hold |
3,402
| – | – | 0.06% | 160 |
|
|
2018
Q3 | $830K | Buy |
3,402
+45
| +1% | +$10.4K | 0.06% | 167 |
|
|
2018
Q2 | $695K | Sell |
3,357
-25
| -0.7% | -$5.31K | 0.05% | 173 |
|
|
2018
Q1 | $698K | Hold |
3,382
| – | – | 0.05% | 172 |
|
|
2017
Q4 | $642K | Buy |
3,382
+7
| +0.2% | +$1.34K | 0.05% | 176 |
|
|
2017
Q3 | $639K | Hold |
3,375
| – | – | 0.05% | 176 |
|
|
2017
Q2 | $589K | Sell |
3,375
-25
| -0.7% | -$4.2K | 0.05% | 179 |
|
|
2017
Q1 | $522K | Sell |
3,400
-100
| -3% | -$15.3K | 0.04% | 181 |
|
|
2016
Q4 | $494K | Hold |
3,500
| – | – | 0.04% | 187 |
|
|
2016
Q3 | $557K | Hold |
3,500
| – | – | 0.05% | 176 |
|
|
2016
Q2 | $517K | Sell |
3,500
-50
| -1% | -$7.38K | 0.05% | 174 |
|
|
2016
Q1 | $503K | Hold |
3,550
| – | – | 0.05% | 179 |
|
|
2015
Q4 | $504K | Hold |
3,550
| – | – | 0.05% | 183 |
|
|
2015
Q3 | $434K | Hold |
3,550
| – | – | 0.04% | 181 |
|
|
2015
Q2 | $461K | Hold |
3,550
| – | – | 0.04% | 196 |
|
|
2015
Q1 | $477K | Hold |
3,550
| – | – | 0.04% | 197 |
|
|
2014
Q4 | $445K | Sell |
3,550
-8
| -0.2% | -$973 | 0.04% | 201 |
|
|
2014
Q3 | $433K | Buy |
3,558
+8
| +0.2% | +$973 | 0.04% | 197 |
|
|
2014
Q2 | $419K | Hold |
3,550
| – | – | 0.04% | 198 |
|
|
2014
Q1 | $427K | Sell |
3,550
-50
| -1% | -$5.95K | 0.04% | 200 |
|
|
2013
Q4 | $401K | Hold |
3,600
| – | – | 0.04% | 205 |
|
|
2013
Q3 | $332K | Hold |
3,600
| – | – | 0.03% | 210 |
|
|
2013
Q2 | $305K | Buy |
+3,600
| New | +$300K | 0.03% | 213 |
|
Other funds holding TMO
Palladium Partners's TMO Position: Q1 2022 in Review
Palladium Partners reduced its Thermo Fisher Scientific (TMO) stake by 0.05% in Q1 2022, selling an estimated $574 and leaving 2,221 shares worth $1.31M. The position accounts for 0.06% of the portfolio, ranked #174.
Palladium Partners first reported a position in TMO in Q2 2013 and has held it in 36 quarters since. The position peaked at $2.21M in Q2 2021. 2,315 funds tracked by Wall St. Rank hold TMO as of Q1 2022.
- Palladium Partners held 2,221 shares of Thermo Fisher Scientific worth $1.31M as of Q1 2022.
- Palladium Partners sold 1 Thermo Fisher Scientific share in Q1 2022, an estimated $574.
- Thermo Fisher Scientific made up 0.06% of Palladium Partners's portfolio in Q1 2022, its #174 holding.
- Palladium Partners first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 36 quarters since.
- Palladium Partners's Thermo Fisher Scientific position peaked at $2.21M in Q2 2021.
- 2,315 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2022.
Based on Palladium Partners's 13F filing for Q1 2022, filed 26 Apr 2022.